27 results
8-K
EX-2.1
STSA
Satsuma Pharmaceuticals Inc
17 Apr 23
SNBL to Acquire Satsuma Pharmaceuticals
6:34am
, options, derivatives and other hedging agreements or arrangements that will be payable upon termination thereof (assuming they were terminated on the date
424B3
6h1xhy 0c
6 May 21
Prospectus supplement
12:00am
8-K
EX-10.2
1kke4g918a3dxzlmi at
1 Mar 21
Satsuma Pharmaceuticals Announces Updated STS101 Development Plan
12:00am
10-K
u447nr0ii9 d5
10 Mar 20
Annual report
4:20pm
424B4
hk7r x2u0z3yrz
13 Sep 19
Prospectus supplement with pricing info
5:08pm